ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ELDN Eledon Pharmaceuticals Inc

2.18
-0.13 (-5.63%)
Pre Mercado
Última actualización: 06:22:30
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Eledon Pharmaceuticals Inc ELDN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.13 -5.63% 2.18 06:22:30
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.31
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202406:30GLOBEEledon Pharmaceuticals Reports First Quarter 2024 Operating..
09/5/202406:00GLOBEEledon Pharmaceuticals to Present Updated Data from Ongoing..
07/5/202406:15EDGAR2Form 8-K - Current report
07/5/202406:05GLOBEEledon Announces Clinical Progress with Tegoprubart in the..
07/5/202406:00GLOBEEledon Pharmaceuticals Announces Oversubscribed $50 Million..
28/3/202415:01GLOBEEledon Pharmaceuticals Reports Fourth Quarter and Full Year..
25/3/202415:56GLOBEEledon Pharmaceuticals Announces 12th Participant Enrolled..
21/3/202409:31GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart in..
14/2/202414:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:01GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
04/1/202415:40GLOBEEledon Pharmaceuticals Highlights Recent Business Milestones..
04/12/202317:00GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
29/11/202315:05GLOBEEledon Pharmaceuticals to Present at Noble Capital Markets'..
09/11/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:01GLOBEEledon Pharmaceuticals Reports Third Quarter 2023 Operating..
08/11/202315:05GLOBEEledon Pharmaceuticals to Present at Jefferies London..
02/11/202315:30EDGAR2Form 8-K - Current report
02/11/202308:05GLOBEEledon Reports Updated Data from Ongoing Phase 1b Trial..
23/10/202306:00GLOBEEledon Pharmaceuticals Strengthens Leadership Team with..
13/10/202306:00GLOBEEledon Pharmaceuticals to Present Data from Ongoing Phase 1b..
03/10/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202316:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202316:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202306:30EDGAR2Form 8-K - Current report
02/10/202306:00GLOBEEledon Pharmaceuticals Appoints Kidney Transplant Specialist..
25/9/202306:00GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart..
20/9/202315:05GLOBEEledon Pharmaceuticals to Participate at the 2023 Cantor..
13/9/202315:42EDGAR2Form 8-K - Current report
11/9/202306:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
06/9/202306:00GLOBEEledon Pharmaceuticals Announces Publication of Data Showing..
05/9/202306:00GLOBEEledon Pharmaceuticals Announces First Participant Dosed in..
16/8/202306:00GLOBEEledon Pharmaceuticals Announces Dosing of 10th Patient in..
10/8/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:05EDGAR2Form 8-K - Current report
10/8/202306:00GLOBEEledon Pharmaceuticals Reports Second Quarter 2023 Operating..
02/6/202307:00GLOBEEledon Pharmaceuticals to Present at Jefferies Healthcare..

Su Consulta Reciente

Delayed Upgrade Clock